共 159 条
[21]
Guyatt GH(2015)The global impact of non-communicable diseases on healthcare spending and national income: a systematic review Eur J Epidemiol 30 251-13
[22]
Crawley L(2013)The financial burden from non-communicable diseases in low- and middle-income countries: a literature review Health Res Policy Syst 11 31-203
[23]
Davidoff F(2006)Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy N Engl J Med 355 2427-9
[24]
Haynes B(2012)Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review Ann Intern Med 156 27-7
[25]
Sackett D(2011)Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations Ann Intern Med 154 602-26
[26]
Sackett DL(2009)Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 193-8
[27]
Rosenberg WM(2015)Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 38 140-82
[28]
Gray JA(2015)The relationship of individual comorbid chronic conditions to diabetes care quality BMJ Open Diabetes Res Care 3 e000080-40
[29]
Richardson PE(2007)Multimorbidity’s many challenges BMJ 334 1016-22
[30]
Hoffmann TC(2015)Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions Patient Relat Outcome Meas 6 117-97